Xlife Net Income Applicable To Common Shares from 2010 to 2026
| XLS Stock | 21.20 1.10 4.93% |
Net Income Applicable To Common Shares | First Reported 2010-12-31 | Previous Quarter 39.4 M | Current Value 25.6 M | Quarterly Volatility 16.7 M |
Check Xlife Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xlife Sciences' main balance sheet or income statement drivers, such as Interest Income of 52.2 M, Selling General Administrative of 4.3 M or Total Revenue of 837.6 K, as well as many indicators such as . Xlife financial statements analysis is a perfect complement when working with Xlife Sciences Valuation or Volatility modules.
Xlife | Net Income Applicable To Common Shares |
The evolution of Net Income Applicable To Common Shares for Xlife Sciences AG provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Xlife Sciences compares to historical norms and industry peers.
Latest Xlife Sciences' Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Xlife Sciences AG over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Xlife Sciences' Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xlife Sciences' overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Xlife Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | 12,577,892 | |
| Geometric Mean | 3,948,027 | |
| Coefficient Of Variation | 132.50 | |
| Mean Deviation | 13,562,014 | |
| Median | 1,050,180 | |
| Standard Deviation | 16,665,353 | |
| Sample Variance | 277.7T | |
| Range | 52.4M | |
| R-Value | 0.73 | |
| Mean Square Error | 138T | |
| R-Squared | 0.53 | |
| Significance | 0.0009 | |
| Slope | 2,412,024 | |
| Total Sum of Squares | 4443.7T |
Xlife Net Income Applicable To Common Shares History
About Xlife Sciences Financial Statements
Xlife Sciences investors use historical fundamental indicators, such as Xlife Sciences' Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Xlife Sciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 39.4 M | 25.6 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Xlife Stock Analysis
When running Xlife Sciences' price analysis, check to measure Xlife Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xlife Sciences is operating at the current time. Most of Xlife Sciences' value examination focuses on studying past and present price action to predict the probability of Xlife Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xlife Sciences' price. Additionally, you may evaluate how the addition of Xlife Sciences to your portfolios can decrease your overall portfolio volatility.